Your browser doesn't support javascript.
loading
The potential hepatoprotective effect of metformin in hepatitis C virus-infected adolescent patients with beta thalassemia major: Randomised clinical trial.
Abdel Monem, Mona S; Farid, Samar F; Abbassi, Maggie M; Youssry, Ilham; Andraues, Nevine G; Hassany, Mohamed; Selim, Yasmeen M M; El-Sayed, Manal H.
Afiliação
  • Abdel Monem MS; Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Farid SF; Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Abbassi MM; Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Youssry I; Pediatric Hematology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Andraues NG; Department of Pediatrics and Pediatric Hematology/Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Hassany M; National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt.
  • Selim YMM; Pediatric Hematology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • El-Sayed MH; Department of Pediatrics and Pediatric Hematology/Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Int J Clin Pract ; 75(6): e14104, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33617679

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Talassemia beta / Metformina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / Talassemia beta / Metformina Idioma: En Ano de publicação: 2021 Tipo de documento: Article